ARTICLE | Clinical News
Chromagen regulatory update
November 4, 1996 8:00 AM UTC
Chromagen received notice of allowance for a U.S. patent covering a composition of matter for fluorescent nucleotide analogs and the uses of the analogs to create internally and end-labeled DNA and RN...